Abrocitinib

ATC D11AH08 · 11 markets · 36 records

Abrocitinib 11 markets · 36 records Forms

US 6 records · 3 strengths

200 mgtabletCibinqo also in CN·AU·GB +4
100 mgtabletCibinqo also in CN·AU·GB +4
50 mgtabletCibinqo also in CN·AU·GB +4

CN 6 records · 3 strengths

200 mgtablet希必可阿布昔替尼 also in US·AU·GB +4
100 mgtablet希必可阿布昔替尼 also in US·AU·GB +4
50 mgtablet希必可阿布昔替尼 also in US·AU·GB +4

AU 4 records · 4 strengths

200 mgtabletCIBINQO abrocitinib 50 mg tablet blister pack also in US·CN·GB +4 unknown
100 mgtabletCIBINQO abrocitinib 50 mg tablet blister pack also in US·CN·GB +4 unknown
50 mgtabletCIBINQO abrocitinib 50 mg tablet blister pack also in US·CN·GB +4 unknown

Records without a stated strength · 1 Cibinqo

GB 3 records · 3 strengths

200 mgtabletCibinqo also in US·CN·AU +4
100 mgtabletCibinqo also in US·CN·AU +4
50 mgtabletCibinqo also in US·CN·AU +4

CA 3 records · 3 strengths

200 mgtabletCibinqo also in US·CN·AU +4
100 mgtabletCibinqo also in US·CN·AU +4
50 mgtabletCibinqo also in US·CN·AU +4

SG 3 records · 3 strengths

200 mgtabletCibinqo also in US·CN·AU +4
100 mgtabletCibinqo also in US·CN·AU +4
50 mgtabletCibinqo also in US·CN·AU +4

ES 3 records · 3 strengths

200 mgtabletCibinqo also in US·CN·AU +4
100 mgtabletCibinqo also in US·CN·AU +4
50 mgtabletCibinqo also in US·CN·AU +4

TW 3 records · 3 strengths

200 mgtabletCibinqo+1喜繽果200毫克膜衣錠 also in US·CN·AU +4
100 mgtabletCibinqo+1喜繽果100毫克膜衣錠 also in US·CN·AU +4
50 mgtabletCibinqo+1喜繽果50毫克膜衣錠 also in US·CN·AU +4

HK 3 records · 1 strengths

Records without a stated strength · 1 Cibinqo

MX 1 records · 1 strengths

Records without a stated strength · 1 Cibinqo

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Cibinqo

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	MX	TW	HK	EU
200 mg tablet	Cibinqo	Cibinqo	Cibinqo	CIBINQO abrocitinib 50 mg tablet blister pack	Cibinqo	希必可阿布昔替尼	Cibinqo	not recorded	Cibinqo 喜繽果200毫克膜衣錠	not recorded	not recorded
100 mg tablet	Cibinqo	Cibinqo	Cibinqo	CIBINQO abrocitinib 50 mg tablet blister pack	Cibinqo	希必可阿布昔替尼	Cibinqo	not recorded	Cibinqo 喜繽果100毫克膜衣錠	not recorded	not recorded
50 mg tablet	Cibinqo	Cibinqo	Cibinqo	CIBINQO abrocitinib 50 mg tablet blister pack	Cibinqo	希必可阿布昔替尼	Cibinqo	not recorded	Cibinqo 喜繽果50毫克膜衣錠	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Cibinqo	not recorded	not recorded	not recorded	not recorded	not recorded	Cibinqo	Cibinqo
not disclosed tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Cibinqo	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in MX and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en MX que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 MX 有记录（未在本表显示）。另有 1 個規格/劑型僅在 MX 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.